CNS Pharmaceuticals IncChange company Symbol lookupSelect an option...CNSP CNS Pharmaceuticals IncJGGC Jaguar Global Growth Corporation ICPSI Computer Programs and Systems IncTKNO Alpha Teknova IncBTM Bitcoin Depot IncRC Ready Capital CorpNEOV NeoVolta IncSCHL Scholastic CorpSIDU Sidus Space IncMGY Magnolia Oil & Gas CorpGo
*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.
|
|
|
|
| |
- Prev Close
- 1.22
- Today's Open
- 1.20
- Day's Range
- 1.17-1.28
- Avg Vol (10-day)
- 25.5K
- Last (time)
- 3:49p ET 09/22/23
- Last (size)
- 5
- 52-Wk Range
0.6105 - 6.90- LowHigh
- 52-Wk Range
% Above Low
The current share price compared to the 52-week low.
- 91.65%
- Historical Volatility
Historical Volatility
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
- 181.5%
- Market Cap
- 4.9M
- Shares Outstanding
- 4.2M
- EPS (TTM, GAAP)
EPS (TTM, GAAP)
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- -9.90
- P/E Ratio (TTM, GAAP)
P/E Ratio (TTM, GAAP)
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- --
- Annual Dividend/Yield
Annual Dividend/Yield
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
- No dividend
- Ex-dividend Date
- No dividend
- Dividend Pay Date
- No dividend
- Beta
Beta
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
- 1.3
- % Held by Institutions
% Held by Institutions
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
- 2.48
- Short Interest(% of float 08/31/23)
Short Interest
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
- 2.98
Latest News
| September 07, 2023 | |
|---|---|
| 8:47 am ET | |
| Accesswire | |
| September 05, 2023 | |
| 8:47 am ET | |
| Accesswire | |
| August 14, 2023 | |
| 8:37 am ET | |
| Accesswire | |
| 7:36 am ET | |
| Accesswire | |
| August 03, 2023 | |
| 8:15 am ET | |
| Accesswire | |
| 8:01 am ET | |
| Accesswire | |
| July 27, 2023 | |
| 9:05 am ET | |
| Accesswire | |
| July 06, 2023 | |
| 12:01 pm ET | |
| Accesswire | |
| July 05, 2023 | |
| 8:45 am ET | |
| Accesswire | |
| Go to all current & historical news | |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.